Medical Affairs

Medical Affairs teams play an essential role in driving asset strategy through insights gathering, raising awareness via clinical and scientific education and using data generation and supplemental clinical studies to improve patient outcomes.

Herspiegel is known for our medical affairs expertise that supports Medical Affairs teams in consistently providing value to patients, physicians, and payers. We specialize in identifying education gaps, raising awareness of the science underlying disease states, and speeding the translation of this information to clinical practice through comprehensive learning opportunities. Herspiegel is a dependable thought partner for medical affairs strategy development and can provide teams with innovative tactical planning tailored to the needs of a diversity of experts in many therapeutic areas.

Herspiegel’s Recent Medical Affairs Project Examples

Medical Affairs Strategy

Collected detailed insights and developed medical objectives and strategic plans that aligned to a portfolio strategy and commercialization critical success factors and strategic imperatives.

Scientific Platform and Lexicon Development

Built a comprehensive and well-referenced strategic resource of key medical messages and developed an asset-specific internal resource of cross-functionally aligned terms and phrases.

Medical Symposia

Worked with internal Medical Affairs teams and external KOL speakers to develop symposia content, as well as event fliers and postcards for conferences and medical meetings.

Advisory Board Development and Facilitation

Developed attendee list, planned agenda and built content for meetings with top thought leaders to identify insights and strategic direction.

Education and Engagement Strategy

Developed innovative medical affairs tactics aligned to objectives to raise awareness of new MOA and commonly misdiagnosed disease state by assessing the medical landscape and providing tools and training to the MSL team.

Medical Annual Planning

Developed medical affairs strategic objectives with accompanying tactical plans and detailed budget estimates.

FDA Real-World Evidence Program Framework White Paper

The FDA is developing a framework for a new Real-World Evidence (RWE) Program to guide the generation of data in support of approval for in-line indications. Read our white paper to learn how the pharmaceutical industry will be impacted.